At Emles Bioventures, we harness collaboration and innovation to uncover how lifestyle, environment, and biology intersect to promote health and prevent disease worldwide.
Research
We combine systems biology, data science, and theoretical modelling to uncover the mechanisms that drive healthy aging.
Our research builds the foundation for translational discoveries in longevity and precision medicine - helping to transform insights into strategies that preserve health and vitality over time.
Our mission
Transform human health by understanding and modifying the fundamental processes of aging.
Our vision
Create breakthrough therapies that extend healthy human lifespan through precision medicine.
Our responsibilities
Committed to scientific excellence, ethical research, and transformative medical innovations.
Partnering with leading research institutions and biotechnology companies to accelerate scientific discovery.
Team
Gabriel Hammond
Chief Executive Officer
James Hume
VP of Operations
James has over 20 years experience in the building and optimisation of teams. This includes over 12 years experience of talent acquisition and management in the Biotech Sector
As the VP Operations James is committed to creating an environment where the team has the platform to excel. Leading the people strategy to provide career growth, recruitment, culture and systems to achieve this. Plus, provide the operational framework to ensure the life changing technologies being developed are able to reach those that need them most.
Dr. Natalia Izotova
Scientific Director - Immunology and Cancer
Natalia is a molecular and cellular immunologist with a background in gene and cell therapy, immuno-oncology, and translational research. Her work explores the links between immunity, environment and lifestyle to inform the development of novel therapeutics for chronic and age-related diseases.
Dr. Sam Orange
Scientific Director - Exercise Science
Sam is an experienced Principal Investigator and exercise physiologist with over 10 years’ experience leading research programmes related to exercise and disease prevention, with a particular focus on cancer. His work spans both translational and clinical research, aiming to develop precision interventions that mimic or optimise the biological effects of exercise.
Dr. Adam Shellard
Scientific Director - Biomarkers
Adam is a Scientific Director specializing in the discovery and translation of fluid biomarkers, driven by a strong commitment to accelerating scientific discoveries for patient benefit.
Dr. Amy Jolly
Scientific Director - Neuroscience
Amy is a cognitive and computational neuroscientist with a background in advanced neuroimaging, working in the field of clinical neurology and translational neuroscience. Her work focuses on developing improved diagnostics and therapeutics for the prevention and treatment of age-related neurodegenerative diseases as well as traumatic brain injury. She focuses on harnessing multimodal big data and machine learning techniques to achieve this.
Dr. Kathleen Shah
Scientific Director - Microbiome & 4P Medicine
Kathleen is a mucosal immunologist specializing in how the environment, diet, and microbiome shape human health. At EMLES Bioventures, she leads programs advancing fecal microbiota transplantation (FMT), including donor screening, matching, and longitudinal health optimization. With a PhD from EPFL, postdoctoral training at the Francis Crick Institute, and industry experience, she applies a systems-level approach to precision health guided by the principles of 4P Medicine - predictive, preventive, personalized, and participatory.
Dr. Emily Thomas
Lead Data Scientist
Emily is the Lead Data Scientist at Emles Bioventures where she leverages data analytics, machine learning, and AI to develop predictive models for individualised health metrics, drawing insights from a range of sources including wearables, blood biomarkers and neuroimaging.
Dr. Thomas Maden-Wilkinson
Scientific Director - Exercise Science
Tom is a physiologist with expertise in muscle and bone health. Tom joined Emles in March 2025 as Director in Exercise Science from academia where he was an associate professor. Tom has previously led studies with Olympians, Elite Athletes, Astronauts and people with long term health conditions and is currently working on a number of projects to optimise muscle health.
Dr. Tom Jameson
Scientific Director - Exercise Science
Tom is an experienced skeletal muscle physiologist with a background spanning both academia and pharmaceutical industries. His work focuses on how physical activity, nutrition, and disease influence skeletal muscle and whole body metabolic health, with a particular focus on the role of inflammation and ageing.
Dr. Claudio Durán
Lead Bioinformatician
Claudio brings over 7 years of experience in bioinformatics, data science and machine learning. His expertise involves the analysis of complex multi-omics data, with a strong emphasis on the microbiome. His primary goal is to leverage rich datasets to create impactful advancements in precision medicine and healthy aging.
Magela Benedetto
Research Associate
Magela has a background in pharmacology and research experience in healthy aging, Medicine 3.0, and the exploration of novel therapeutics to evaluate their potential for advancing healthcare.
Martyna Debska
Research Associate
Martyna holds a background in neuroscience and works at the intersection of biotechnology, health, and longevity. At Emles, she supports lead scientists across multiple projects in the Medicine 3.0 and personalised healthcare space. Her work includes conducting literature-based investigations to identify promising therapeutic avenues, as well as supporting and contributing to different projects and teams across key health areas, including healthy brain ageing, cell therapies, and biomarker optimisation.
Join our team
Passionate scientists wanted to revolutionize human health
Join Us in Advancing Longevity Science